 Proto-Oncogene Proteins c-maf
"Proto-Oncogene Proteins c-maf" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Maf proto-oncogene protein is the major cellular homolog of the V-MAF ONCOGENE PROTEIN. It was the first of the mammalian MAF TRANSCRIPTION FACTORS identified, and it is induced in activated T-LYMPHOCYTES and regulates GENETIC TRANSCRIPTION of INTERLEUKIN-4. c-maf is frequently translocated to an immunoglobulin locus in MULTIPLE MYELOMA.
| Descriptor ID |
D051257
|
| MeSH Number(s) |
D12.776.260.108.500.061.750 D12.776.624.664.700.184 D12.776.930.127.500.061.750
|
| Concept/Terms |
Proto-Oncogene Proteins c-maf- Proto-Oncogene Proteins c-maf
- Proteins c-maf, Proto-Oncogene
- Proto Oncogene Proteins c maf
- c-maf, Proto-Oncogene Proteins
- c-maf Proto-Oncogene Protein
- Proto-Oncogene Protein, c-maf
- Proto-Oncogene Protein c-maf
- Proto Oncogene Protein c maf
- c-maf, Proto-Oncogene Protein
- c-maf Protein
- maf Proto-Oncogene Protein
- Proto-Oncogene Protein, maf
- maf Proto Oncogene Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-maf".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-maf".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-maf" by people in UAMS Profiles by year, and whether "Proto-Oncogene Proteins c-maf" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-maf" by people in Profiles over the past ten years.
-
Choudhury SR, Ashby C, Tytarenko R, Bauer M, Wang Y, Deshpande S, Den J, Schinke C, Zangari M, Thanendrarajan S, Davies FE, van Rhee F, Morgan GJ, Walker BA. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma. J Hematol Oncol. 2020 08 06; 13(1):108.
-
Qiang YW, Ye S, Chen Y, Buros AF, Edmonson R, van Rhee F, Barlogie B, Epstein J, Morgan GJ, Davies FE. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma. Blood. 2016 12 22; 128(25):2919-2930.
-
Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, Proszek PZ, Melchor L, Pawlyn C, Kaiser MF, Johnson DC, Qiang YW, Jones JR, Cairns DA, Gregory WM, Owen RG, Cook G, Drayson MT, Jackson GH, Davies FE, Morgan GJ. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015 Apr 23; 6:6997.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|